Fabricated porous silk fibroin particles for pH-responsive drug delivery and targeting of tumor cells
Source abstract
Abstract
To improve the roles of tumor drug, porous silk fibroin particles have been designed as drug carriers. Doxorubicin (DOX) is encapsulated during the fabrication process of the silk fibroin particles to form DOX loaded silk fibroin particles (SFPs-DOX). Folic acid (FA) is covalently grafted to the surface of the silk fibroin particles (FA-SFPs-DOX) as a target group to the folate receptor of tumor cells. The experimental results showed that under the conditions of low pH, high ionic strength and high enzyme concentration, the release of loaded drugs in particles has stimulus response under various conditions. The synthesized silk fibroin particles have good biocompatibility. The specific binding of fibroin particles to folate receptors provides the particles to with target functions to the tumor cells. The job develops potential application of silk fibroin particles as smart drug carriers for the targeted therapy of tumor.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Silk-based biomaterials and applications · RNA Interference and Gene Delivery · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Such GK, Yan Y, Johnston APR, Gunawan ST, Caruso F (2015) Interfacing materials science and biology for drug carrier design. Adv Mater 27:2278–229710.1002/adma.201405084 ↗
2. Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC (2008) Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 127:208–21810.1016/j.jconrel.2008.01.013 ↗
3. Du JZ, Du XJ, Mao CQ, Wang J (2011) Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc 133:17560–1756310.1021/ja207150n ↗
4. Shi Y, Wang M, Ma CB, Yu GH (2015) A conductive self-healing hybrid gel enabled by metal-ligand supramolecule and nanostructured conductive polymer. Nano Lett 15:6276–628110.1021/acs.nanolett.5b03069 ↗
5. Pérez-Herrero E, Fernández-Medarde A (2015) Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm 93:52–7910.1016/j.ejpb.2015.03.018 ↗
6. Chang BS, Sha XY, Guo J, Jiao YF, Wang CC, Yang WL (2011) Thermo and pH dual responsive, polymer shell coated, magnetic mesoporous silica nanoparticles for controlled drug release. J Mater Chem 21:9239–924710.1039/c1jm10631g ↗
7. Horan RL, Antle K, Collette AL, Wang YZ, Huang J, Moreau JE, Volloch V, Kaplan DL, Altman GH (2005) In vitro degradation of silk fibroin. Biomaterials 26:3385–339310.1016/j.biomaterials.2004.09.020 ↗
8. Shi LB, Cai HX, Chen LK, Wu Y, Zhu SA, Gong XN, Xia YX, Ouyang HW, Zou XH (2014) Tissue engineered bulking agent with adipose-derived stem cells and silk fibroin microspheres for the treatment of intrinsic urethral sphincter deficiency. Biomaterials 35:1519–153010.1016/j.biomaterials.2013.11.025 ↗
9. Wongpinyochit T, Uhlmann P, Urquhart AJ, Seib FP (2015) PEGylated silk nanoparticles for anticancer drug delivery. Biomacromol 16:3712–372210.1021/acs.biomac.5b01003 ↗
10. Brown JE, Partlow BP, Berman AM, House MD, Kaplan DL (2016) Injectable silk-based biomaterials for cervical tissue augmentation: an in vitro study. Am J Obstet Gynecol 214:118e1–118e910.1016/j.ajog.2015.08.046 ↗
11. Shi JJ, Votruba AR, Farokhzad OC, Langer R (2010) Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 10:3223–323010.1021/nl102184c ↗
12. Shchepelina O, Drachuk I, Gupta MK, Lin J, Tsukruk VV (2011) Silk-on-silk layer-by-layer microcapsules. Adv Mater 23:4655–466010.1002/adma.201102234 ↗
13. Wang Q, Jian MQ, Wang CY, Zhang YY (2017) Carbonized silk nanofiber membrane for transparent and sensitive electronic skin. Adv Func Mater 27:1605657–160566610.1002/adfm.201605657 ↗
14. Subia B, Dey T, Sharma S, Kundu SC (2015) Target specific delivery of anticancer drug in silk fibroin-based 3D distribution model of bone-breast cancer cells. ACS Appl Mater Interfaces 7:2269–227910.1021/am506094c ↗
15. Vepari C, Kaplan DL (2007) Silk as a biomaterial. Prog Polym Sci 32:991–100710.1016/j.progpolymsci.2007.05.013 ↗
16. Tian Y, Jiang XJ, Chen X, Shao ZZ, Yang WL (2014) Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant cancer. Adv Mater 26:7393–739810.1002/adma.201403562 ↗
17. Yang MY, Zhou GS, Shuai YJ, Wang J, Zhu LJ, Mao CB (2014) Tuning molecular weights of Bombyx mori (B. mori) silk sericin to modify its assembly structures and materials formation. ACS Appl Mater Interfaces 16:13782–1378910.1021/am503214g ↗
18. Yang MY, Shuai YJ, Zhang C, Chen YY, Zhu LJ, Mao CB (2014) Biomimetic nucleation of hydroxyapatite crystals mediated by Antheraea pernyi (A. pernyi) silk sericin promotes osteogenic differentiation of human bone marrow derived mesenchymal stem cells. Biomacromol 15:1185–119310.1021/bm401740x ↗
19. Wu J, Liu L, Cai YR, Yao JM (2013) Recent advances of calcium phosphate nanoparticles for controlled drug delivery. Mini Rev Med Chem 13:1501–150710.2174/13895575113139990059 ↗
20. Xu S, Olenyuk BZ, Okamoto CT, Hamm-Alvarez SF (2013) Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advance. Adv Drug Deliv Rev 65:121–13810.1016/j.addr.2012.09.041 ↗
21. Guan XW, Li YH, Jiao ZX, Chen J, Guo ZP, Tian HY, Chen XS (2013) A pH-sensitive charge-conversion system for doxorubicin delivery. Acta Biomater 9:7672–767810.1016/j.actbio.2013.04.047 ↗
22. Huang L, Tao KX, Liu J, Qi C, Xu LM, Chang PP, Gao JB, Shuai XM, Wang GB, Wang Z, Wang L (2016) Design and fabrication of multifunctional sericin nanoparticles for tumor targeting and ph-responsive subcellular delivery of cancer chemotherapy drugs. ACS Appl Mater Interfaces 8:6577–658510.1021/acsami.5b11617 ↗
23. Subia B, Kundu SC (2013) Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers. Nanotechnology 24:03510310.1088/0957-4484/24/3/035103 ↗
24. Lammel AS, Hu X, Park SH, Kaplan DL, Scheibel TR (2010) Controlling silk fibroin particle features for drug delivery. Biomaterials 31:4583–459110.1016/j.biomaterials.2010.02.024 ↗
25. El-Gogary RI, Rubio N, Wang JT, Al-Jamal WT, Bourgognon M, Kafa H, Naeem M, Klippstein R, Abbate V, Leroux F, Bals S, Tendeloo GV, Kamel AO, Awad GAS, Mortada ND, Al-Jamal KT (2014) Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo. ACS Nano 8:1384–140110.1021/nn405155b ↗
26. Banerjee SS, Chen DH (2008) Multifunctional pH-sensitive magnetic nanoparticles for simultaneous imaging, sensing and targeted intracellular anticancer drug delivery. Nanotechnology 19:50510410.1088/0957-4484/19/50/505104 ↗
27. Shi JJ, Zhang HL, Wang L, Li LL, Wang HH, Wang ZZ, Li Z, Chen CQ, Hou L, Zhang CF, Zhang ZZ (2013) PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Biomaterials 34:251–26110.1016/j.biomaterials.2012.09.039 ↗
28. Chen FH, Zhang LM, Chen QT, Zhang Y, Zhang ZJ (2010) Synthesis of a novel magnetic drug delivery system composed of doxorubicin-conjugated Fe3O4 nanoparticle cores and a PEG-functionalized porous silica shell. Chem Commun 46:8633–863510.1039/c0cc02577a ↗
29. Seib FP, Kaplan DL (2012) Doxorubicin-loaded silk films: drug-silk interactions and in vivo performance in human orthotopic breast cancer. Biomaterials 33:8442–845010.1016/j.biomaterials.2012.08.004 ↗
30. Lu YJ, Low PS (2012) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 64:342–35210.1016/j.addr.2012.09.020 ↗
31. Liu JQ, Cui L, Losic D (2013) Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater 9:9243–925710.1016/j.actbio.2013.08.016 ↗
32. Guo X, Shi CL, Yang G, Wang J, Cai ZH, Zhou SB (2014) Dual-responsive polymer micelles for target-cell-specific anticancer drug delivery. Chem Mater 26:4405–441810.1021/cm5012718 ↗
33. Ma NX, Liu J, He WX, Li ZH, Luan YX, Song YM, Garg S (2017) Folic acid-grafted bovine serum albumin decorated graphene oxide: an efficient drug carrier for targeted cancer therapy. J Colloid Interface Sci 490:598–60710.1016/j.jcis.2016.11.097 ↗
34. Shuai XT, Ai H, Nasongkla N, Gao JM (2004) cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed Engl 43:6323–632710.1002/anie.200460800 ↗